latest news stock values companies glp-1 obesity cardiometabolic How to Invest in Drugs: Stocks and Funds to Watch GLP-1 Receptor Agonist Market Growth

Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a persons overall risk of developing the disease

While these medications are also available in pill form, the majority of FDA-approved GLP-1 treatments are delivered via injection

They can be interpreted as the average number of T2D patients who would need to be treated with a GLP-1RA relative to insulin for a given follow-up period of time to prevent one case with a clinical outcome of interest

The medication enters your bloodstream intact with a bioavailability of approximately 89%, the expert explains